A
Aker Biomarine ASA
OSE:AKBM
Aker Biomarine ASA
OSE:AKBM
Price:
57.8
NOK
3.21%
Market Closed
Market Cap:
5.1B
NOK
Cash Flow Statement
Cash Flow Statement
Aker Biomarine ASA
Aker Biomarine ASA
Currency: USD
Millions
TTM
| Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Net Income |
(24)
|
(18)
|
(28)
|
(26)
|
(5)
|
(14)
|
(8)
|
3
|
(8)
|
(8)
|
10
|
1
|
10
|
2
|
(15)
|
(19)
|
(9)
|
(3)
|
(0)
|
206
|
182
|
|
| Depreciation & Amortization |
37
|
43
|
44
|
47
|
48
|
50
|
52
|
58
|
51
|
52
|
50
|
45
|
51
|
50
|
50
|
51
|
52
|
57
|
61
|
50
|
45
|
|
| Other Non-Cash Items |
29
|
34
|
32
|
23
|
22
|
18
|
24
|
24
|
23
|
22
|
(8)
|
(5)
|
8
|
15
|
40
|
43
|
9
|
10
|
13
|
(228)
|
(205)
|
|
| Cash Interest Paid |
17
|
21
|
20
|
24
|
31
|
29
|
27
|
12
|
13
|
14
|
14
|
15
|
18
|
21
|
25
|
30
|
30
|
32
|
34
|
28
|
20
|
|
| Change in Working Capital |
(30)
|
(26)
|
(30)
|
(66)
|
(116)
|
(113)
|
(132)
|
(103)
|
(66)
|
(64)
|
(45)
|
(45)
|
(55)
|
(55)
|
(70)
|
(51)
|
(5)
|
(12)
|
(5)
|
23
|
(9)
|
|
| Cash from Operating Activities |
12
N/A
|
33
+166%
|
19
-42%
|
(23)
N/A
|
(51)
-125%
|
(59)
-16%
|
(63)
-6%
|
(17)
+73%
|
1
N/A
|
2
+118%
|
7
+362%
|
(4)
N/A
|
15
N/A
|
12
-18%
|
5
-61%
|
25
+417%
|
47
+91%
|
51
+8%
|
69
+34%
|
52
-25%
|
12
-76%
|
|
| Investing Cash Flow | ||||||||||||||||||||||
| Capital Expenditures |
(127)
|
(35)
|
(31)
|
(42)
|
(24)
|
(74)
|
(76)
|
(68)
|
(81)
|
(33)
|
(37)
|
(41)
|
(46)
|
(47)
|
(45)
|
(45)
|
(49)
|
(46)
|
(43)
|
(35)
|
(23)
|
|
| Other Items |
(49)
|
0
|
22
|
22
|
22
|
22
|
(0)
|
(0)
|
2
|
2
|
(9)
|
(9)
|
(10)
|
0
|
0
|
1
|
0
|
1
|
0
|
409
|
402
|
|
| Cash from Investing Activities |
(176)
N/A
|
(35)
+80%
|
(9)
+76%
|
(20)
-138%
|
(2)
+90%
|
(53)
-2 469%
|
(76)
-44%
|
(68)
+11%
|
(79)
-16%
|
(31)
+61%
|
(46)
-48%
|
(51)
-11%
|
(56)
-11%
|
(57)
-2%
|
(45)
+22%
|
(44)
+1%
|
(49)
-11%
|
(45)
+8%
|
(42)
+6%
|
374
N/A
|
379
+1%
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
224
|
224
|
224
|
224
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
175
|
8
|
(6)
|
(190)
|
(174)
|
(110)
|
(92)
|
92
|
79
|
34
|
43
|
48
|
52
|
56
|
38
|
25
|
7
|
(4)
|
(22)
|
(57)
|
(31)
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(373)
|
(373)
|
|
| Other |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
175
N/A
|
8
-96%
|
(6)
N/A
|
34
N/A
|
50
+47%
|
114
+128%
|
133
+16%
|
92
-31%
|
79
-14%
|
34
-56%
|
43
+26%
|
48
+12%
|
53
+8%
|
56
+6%
|
38
-33%
|
24
-35%
|
7
-73%
|
(4)
N/A
|
(22)
-443%
|
(430)
-1 881%
|
(404)
+6%
|
|
| Change in Cash | ||||||||||||||||||||||
| Net Change in Cash |
11
N/A
|
5
-52%
|
4
-20%
|
(9)
N/A
|
(3)
+67%
|
2
N/A
|
(7)
N/A
|
7
N/A
|
0
-93%
|
5
+1 036%
|
5
-7%
|
(6)
N/A
|
11
N/A
|
11
-4%
|
(2)
N/A
|
5
N/A
|
5
N/A
|
2
-58%
|
5
+123%
|
(4)
N/A
|
(13)
-229%
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
(115)
N/A
|
(3)
+98%
|
(12)
-325%
|
(65)
-454%
|
(75)
-15%
|
(134)
-79%
|
(139)
-4%
|
(85)
+39%
|
(80)
+6%
|
(31)
+61%
|
(29)
+6%
|
(45)
-55%
|
(31)
+32%
|
(35)
-12%
|
(41)
-17%
|
(20)
+51%
|
(2)
+90%
|
6
N/A
|
26
+360%
|
17
-34%
|
(11)
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
